Mantle Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mantle Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma [Phase 2]
Phase 2 trial update for an autologous tumor vaccine approach using GM-CSF–producing cells and GM.CD40L in mantle cell lymphoma, with result…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab with interleukin-12 in several B-cell non-Hodgkin lymphomas. The study status is completed.
-
CLINICAL_TRIALS research · 2013-08-02Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation in patients with mantle cell lymphoma; current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma [Phase 2]
Phase 2 trial of antineoplaston therapy for mantle cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a combination of chemotherapy, radiation therapy, and peripheral stem cell transplantation in patients with sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating rituximab in combination with interleukin-2 in various hematologic cancers has completed.
-
CLINICAL_TRIALS withdrawal · 2013-06-06Clinical Trial Update: Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating obatoclax mesylate in combination with rituximab and bendamustine hydrochloride for relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating decitabine with or without valproic acid in relapsed or refractory non-Hodgkin lymphoma, including Burkitt lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma [Phase 1]
Phase 1 study evaluating a combination of alvocidib, fludarabine phosphate, and rituximab in various B-cell lymphoproliferative disorders, w…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of tanespimycin (17-allylamino-17-demethoxygeldanamycin) and bortezomib in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [Phase 1]
This Phase 1 trial evaluated bortezomib in patients with advanced cancer and kidney dysfunction. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating PXD101 in combination with 17-N-allylamino-17-demethoxygeldanamycin for metastatic or unresectable solid tumors o…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study evaluating belinostat (PXD101) in combination with bortezomib in adults with advanced solid tumors or lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 study of canfosfamide in refractory or relapsed mantle cell lymphoma, B-cell lymphoma, and m…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Sorafenib in adults with recurrent non-Hodgkin lymphoma, including Anaplastic Large Cell Lymphoma, Diffuse Large B-…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating flavopiridol in patients with recurrent intermediate- or high-grad…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 2]
Phase 2 clinical trial S0601 evaluating rituximab plus a chemotherapy regimen followed by bortezomib, then bortezomib alone, in newly diagno…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bevacizumab in patients with various non-Hodgkin lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial evaluating 17-DMAG (alvespimycin), an HSP90 inhibitor, in patients with metastatic or unresectable solid tumors or ly…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma [Phase 1]
An update on a Phase 1 trial of oblimersen in combination with gemcitabine for patients with advanced solid tumors or lymphoma, which has be…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for cilengitide in patients with advanced solid tumors or lymphoma, with the study status reported as completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update evaluating oblimersen with rituximab and combination chemotherapy in relapsed or refractory aggressi…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas [Phase 1]
This Phase 1 trial evaluated entinostat (MS-275) plus isotretinoin in adults with metastatic or advanced solid tumors or various lymphomas; …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluated oxaliplatin in patients with relapsed or refractory non-Hodgkin lymphoma across multiple subtypes and has complete…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma [Phase 1]
Phase 1 trial of CEP-9722 in combination with gemcitabine and cisplatin in patients with advanced solid tumors or mantle cell lymphoma has c…